Theoretical applied approaches to improving sectoral regulation of the process of forming a socially-oriented assortment of medicines in the domestic pharmaceutical market
DOI:
https://doi.org/10.24959/uekj.18.4Keywords:
assortment policy, sectoral regulation, pharmaceutical market regulation, social function of pharmaceutical, socially-oriented assortment policy, pharmaceutical marketAbstract
In most of the countries that experienced the turning point in their development, the state and society as a whole took responsibility for providing the population with a socially-oriented assortment of medicines. Due to an effective system of production sectoral regulation and drug use, the socially determined level of access to medicines remains an important constant that allows stability in society to be safeguarded.
Aim. To substantiate and develop theoretical applied approaches to improving sectoral regulation of the process of forming a socially – oriented assortment of medicines in the domestic pharmaceutical market.
Materials and methods. The research used data from specialized literature and the results of research by foreign and domestic scientists on the sectoral regulation of the pharmaceutical market in the direction of forming a socially-oriented assortment of medicines. Achievement of the stated goal of research was carried out using the methods of historical, comparative, systemic and logical modeling.
Results. The article presents the results of systematization of experience of the functioning of sectoral for regulating the pharmaceutical market in the direction of forming a socially oriented assortment of medicines in the EU countries. The levels are defined, advantages and disadvantages of functioning of the developed (multiple) and vertical (centralized) model of sectoral regulation of medicine turnover and assortment policy in the pharmaceutical market in the EU countries are indicated. It is established that the regulation of assortment policy in the pharmaceutical market in the EU countries is implemented at all stages of medicine promotion through the commodity distribution network using a set of tools. In turn, the regulation of the process of forming a socially – oriented assortment of medicines at the stage of their consumption is carried out in accordance with the levels of rendering pharmaceutical assistance to the population. At the same time, the most important social significance is the mechanisms for compensating the cost of drugs in a wide range of their introduction into the system of pharmaceutical provision of the population. The authors formulated the main tasks and principles of effective implementation of socially oriented assortment policy in the domestic pharmaceutical market at all stages of the commodity distribution chain of goods promotion and in accordance with the level of pharmaceutical care.
Conclusions. Regulation of the process of forming a socially-oriented assortment of medicines in the pharmaceutical market in the conditions of reforming the health care system and the social and economic crisis in the state should be carried out in a wide range of state influence through the use of a set of mechanisms (pricing, taxation, insurance, investment, credit), as well as taking into account the levels of pharmaceutical assistance.
References
Nemchenko, A. S., Kotvitska, A. A., Panfilova, H. L. (2017) Formuvannia natsionalnoi likarskoi polityky za umov vprovadzhennia medychnoho strakhuvannia: pytannia osvity, teorii ta praktyky. Kharkiv: NUPh, 3–12.
Kotvitska, A. A. (2008). Metodolohiia sotsialno efektyvnoi orhanizatsii farmatsevtychnoho zabezpechennia naselennia. Kharkiv, 43.
Kosiachenko, K. L. (2012). Teoretychne obgruntuvannia ta realizatsiia sotsialno–ekonomichnykh pryntsypiv tsinoutvorennia na likarski zasoby v Ukraini. Kharkiv, 44.
Kubarieva, I. V. (2009). Naukovo–metodychni pidkhody do formuvannia sotsialno–ekonomichnoi systemy tsin na likarski zasoby. Kharkiv, 24.
Nemchenko, A. S., Kosyiachenko, K. L., Nemchenko, O. A. (2012). Tsiny ta tsinoutvorennia na likarski zasoby. Kharkiv: Apostrof, 304.
Mnushko, Z. N. Pestun, I. V. (2008). Teoriia i praktika marketyngovykh issledovanii v farmatcii. Kharkov: NUPh, 308.
Khomenko, V. M. (2008). Teoretychne obgruntuvannia ta realizatsiia suchasnykh pryntsypiv derzhavnoho upravlinnia farmatsiieiu v Ukraini. Kharkiv, 45.
Podpruzhnikov, Yu. V., Nemchenko, A. S., Andriukova, L. N., Gumeniuk, N. I. (2017). Sistema kachestva i nadlezhashchie praktiki v farmatcii. Kharkiv: SIK HRUP Ukraina, 652.
Parnovskyi, B. L., Zaliska, O. M., Vytrykush, L. I., Kozii, L. D. (2012). Farmatsevt Praktyk, (9), 20–21.
Holubka, V. M. (2015). Ekonomichnyi forum, (2), 18–30.
Holubka, V. M. (2014). Naukovi pratsi NDFI, 4 (69), 9–18.
Dudchak, I. B. (2007). Derzhavne rehuliuvannia rozvytku farmatsevtychnoho rynku v Ukraini. Lviv, 25.
Susharina, I. V., Nemchenko, A. S., Khomenko, V. M. (2017). Farmatsevtychnyi chasopys, (1), 38–44. doi: 10.11603/2312–0967.2017.1.7529
Fomin, A. V. (2013). Dinamicheskaia model ravnovesiia farmatcevticheskogo rynka. Moscow, 28.
Policy Options for Promoting the Use of Generic Medicines in Lowand Middle–income Countries (2016). Available at: http://haiweb.org/wp–content/uploads/2017/02/HAI_Review_generics_policies_final.pdf
Mossialos, E., Mrazek, M., Walley, T. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Available at: http://www.euro.who.int/__data/assets/pdf_file/0008/98432/E83015.pdf
Nemchenko, A. S., Panfilova, H. L., Propisnova, V. V. (2009). Klinichna farmatsiia, 1, 31–36.
Panfilova, H. L. (2014). Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 2, 89 – 97.
Levashova, I. G., Murashko, A. N., Podpruzhnikov, Yu. V. (2006). Nadlezhashchye praktiki v farmatcii. Kiev: Morion, 256.
Rehuliuvannia rynku likarskykh zasobiv:problemy ta rishennia. Analitychnyi tsentr «Nova sotsialna ta ekonomichna polityka» Proekt zvitu. Available at: http://newsep.com.ua/media/news/816/files/PROEKT
Starostenko, H. H., Onyshko, S. V., Posnova, T. V. (2015) Natsionalna ekonomika ta ekonomichna bezpeka. Kyiv: Lira–K, 432.
Pharmaceutical spending per capita in selected countries in 2013. Available at: http://www.statista.com/statistics/266141/pharmaceutical–spending percapita–in–selected–countries
23. The Pharmaceutical Industry in figures – Edition 2012. European Federation of Pharmaceutical Industries and Associations. Available at: http://www.efpia.eu/topics/industry–economy/facts–figures–2
Kotvitska, A. A., Kubarieva, I. V. (2015). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 6 (44), 85–89.
Informatsiia pro zdiisnennia derzhavnykh zakupivel likarskykh zasobiv ta medychnykh vyrobiv iz zaluchenniam spetsializovanykh orhanizatsii. Available at: http://www.moz.gov.ua/ua/portal/pre_20170612_b.html
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
